Edition:
United States

Trillium Therapeutics Inc (TRIL.OQ)

TRIL.OQ on NASDAQ Stock Exchange Capital Market

7.75USD
14 Dec 2017
Change (% chg)

$-0.60 (-7.19%)
Prev Close
$8.35
Open
$8.15
Day's High
$8.45
Day's Low
$7.60
Volume
55,887
Avg. Vol
20,551
52-wk High
$13.30
52-wk Low
$4.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.050
Jun '17 0.00 -1.405
Mar '17 0.00 -1.460
FY 2016 Dec '16 0.00 -1.151
Sep '16 0.00 -1.011
Jun '16 0.00 -0.973
Mar '16 0.00 -0.922
FY 2015 Dec '15 0.00 -0.402
Sep '15 0.00 -0.205
Jun '15 0.00 -0.796
Mar '15 0.00 -0.980
 
*Note: Units in Millions ofCanadian Dollars
**Note: Units in Canadian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 2 -1.25 -1.00 -1.51 -0.51
Quarter Ending Mar-18 1 -0.97 -0.97 -0.97 --
Year Ending Dec-17 1 -5.55 -5.55 -5.55 -2.58
Year Ending Dec-18 2 -3.79 -3.70 -3.87 --
Sales and Profit Figures in Canadian Dollar (CAD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta 2.11 0.82 0.91
Price to Sales (TTM) -- 117.54 5.90
Price to Book (MRQ) 8.87 23.08 5.74
Price to Tangible Book (MRQ) 2.29 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions -- 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -3.88 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -53.10 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -- 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 6.33 5.63 3.57
LT Debt to Equity (MRQ) 0.19 16.33 13.26
Total Debt to Equity (MRQ) 0.19 18.85 19.22
Interest Coverage (TTM) -22.54 -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -- -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -- -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -- -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,216,302 857,902,259
Net Income/Employee (TTM) -- -2,116,531 100,310,105
Receivable Turnover (TTM) -- 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.77 -9.39 11.35
Return on Assets - 5 Yr. Avg. -34.13 0.13 12.32
Return on Investment (TTM) -64.28 -11.69 14.48
Return on Investment - 5 Yr. Avg. -36.26 3.37 16.13
Return on Equity (TTM) -189.66 -36.44 16.06
Return on Equity - 5 Yr. Avg. -60.99 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -82.91 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Trillium Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.06%
# of Holders: 25
Total Shares Held: 8,037,070
3 Mo. Net Change: 2,288,603
# New Positions: 4
# Closed Positions: 9
# Increased Positions: 11
# Reduced Positions: 12
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.